Patent Injustice: How world trade rules threaten the health of poor people

dc.date.accessioned	2010-10-29T13:05:35Z	en
dc.date.available	2010-10-29T13:05:35Z	en
dc.date.issued	2001-02-01
dc.identifier.isbn	978-1-84814-141-4
dc.identifier.uri	http://hdl.handle.net/10546/114044
dc.description	This paper shows how new global patent rules, introduced by the World Trade Organisation, will raise the costs of vital medicines, with potentially disastrous implications for poor countries. In brief, these rules require all countries to provide patent protection for a minimum of 20 years for inventions in all fields of technology, including medicines. As the report points out, in the pharmaceutical sector the winners will be the large northern-based transnational companies which, as a result of the lengthened patent protection provided by WTO rules, will be able to sell their new medicines at higher prices. The losers are likely to be the millions of people who will be unable to afford vital new medicines, and hardpressed government health services.	en_US
dc.format.extent	37	en_US
dc.format.mimetype	PDF	en_US
dc.language.iso	English	en_US
dc.language.iso	Spanish	en_US
dc.publisher	Oxfam GB	en_US
dc.relation.url	https://policy-practice.oxfam.org.uk/publications/patent-injustice-how-world-trade-rules-threaten-the-health-of-poor-people-114044
dc.subject	Health
dc.title	Patent Injustice: How world trade rules threaten the health of poor people	en_US
dc.type	Briefing paper	en_US
oxfam.signoff.status	For public use. Can be shared outside Oxfam.	en_US
oxfam.subject.keyword	Access to medicines	en_US
oxfam.subject.keyword	TRIPS and patents	en_US
oxfam.subject.keyword	World Trade Organisation	en_US
oxfam.subject.keyword	WTO	en_US
refterms.dateFOA	2018-08-20T10:59:38Z